View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

PRoMPT BOLUS

Clinicaltrials.gov ID: NCT04102371

What is the goal of the study?

Sepsis is a severe infection that requires emergency treatment with IV fluids and antibiotics. This phase 3 study will determine which of two commonly used intravenous fluids is most effective to treat children with sepsis

Who can participate in the study?

This study may be a good fit for children who: Are between the ages of 6 months and 18 years Are suspected to have sepsis by their medical team in the Emergency Department

Study Team:

PI (Study Doctor): Neil Uspal
Study Team Member: Alister Lobo, alister.lobo@seattlechildrens.org